Arylamine N-acetyltransferase 1 (NAT1) was shown to catalyze the N- or O-acetylation of different arylamine and heterocyclic amine substrates and was observed to be involved in tumor progression and chemotherapy resistance (30). Here, NAT1 is linked to neoplasm.